Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec : results from gener8-1
M. C. Ozelo, J. Mahlangu, B. Madan, J. Mason, F. Peyvandi, A. V. Drygalski, G. Yamaguti-Hayakawa, T. M. Robinson, S. W. Pipe, T. T. Gener-Eigh
Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec : results from gener8-1
M. C. Ozelo, J. Mahlangu, B. Madan, J. Mason, F. Peyvandi, A. V. Drygalski, G. Yamaguti-Hayakawa, T. M. Robinson, S. W. Pipe, T. T. Gener-Eigh
Bleeding, FVIII activity, and safety 3 years after gene transfer with valoctocogene roxaparvovec : results from gener8-1
M. C. Ozelo, J. Mahlangu, B. Madan, J. Mason, F. Peyvandi, A. V. Drygalski, G. Yamaguti-Hayakawa, T. M. Robinson, S. W. Pipe, T. T. Gener-Eigh
Fontes
|
Hematology, transfusion and cell therapy (Fonte avulsa) |